AMAG Pharmaceuticals organizacji Current ratio
Jaka jest wartość Current ratio organizacji AMAG Pharmaceuticals?
Wartość Current ratio organizacji AMAG Pharmaceuticals, Inc. to 1.75
Jaka jest definicja Current ratio?
Wskaźnik bieżącej płynności to wskaźnik płynności, który określa, czy firma ma wystarczające zasoby, aby wywiązać się z zobowiązań krótkoterminowych.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio firm w Health Care sektor na NASDAQ w porównaniu do AMAG Pharmaceuticals
Czym się zajmuję organizacja AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Firmy z current ratio podobne do AMAG Pharmaceuticals
- Wartość Current ratio organizacji Deep Down to 1.75
- Wartość Current ratio organizacji Balaji Amines to 1.75
- Wartość Current ratio organizacji Loyal Equipments to 1.75
- Wartość Current ratio organizacji Pix Transmissions to 1.75
- Wartość Current ratio organizacji AEX Gold to 1.75
- Wartość Current ratio organizacji AEX Gold to 1.75
- Wartość Current ratio organizacji AMAG Pharmaceuticals to 1.75
- Wartość Current ratio organizacji WH to 1.75
- Wartość Current ratio organizacji ICL to 1.75
- Wartość Current ratio organizacji Aura Resources to 1.75
- Wartość Current ratio organizacji Baccarat S.A to 1.75
- Wartość Current ratio organizacji Tsingtao Brewery to 1.75
- Wartość Current ratio organizacji DIRTT Environmental Solutions Ltd to 1.75